Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,147
archived clinical trials in
Asthma

Study to Evaluate the Effectiveness and Safety of MK-1029 in the Treatment of Persistent Asthma That is Not Controlled With Montelukast (ML) in Adults (MK-1029-011 AM2)
A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Crossover Study of MK-1029 in Adult Subjects With Persistent Asthma Who Remain Uncontrolled While Being Maintained on Montelukast
Status: Enrolling
Updated:  12/18/2013
Clinical Research Facility
617
mi
from 98109
Roseville, CA
Study to Evaluate the Effectiveness and Safety of MK-1029 in the Treatment of Persistent Asthma That is Not Controlled With Montelukast (ML) in Adults (MK-1029-011 AM2)
A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Crossover Study of MK-1029 in Adult Subjects With Persistent Asthma Who Remain Uncontrolled While Being Maintained on Montelukast
Status: Enrolling
Updated: 12/18/2013
Clinical Research Facility
617
mi
from 98109
Roseville, CA
Click here to add this to my saved trials
Study to Evaluate the Effectiveness and Safety of MK-1029 in the Treatment of Persistent Asthma That is Not Controlled With Montelukast (ML) in Adults (MK-1029-011 AM2)
A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Crossover Study of MK-1029 in Adult Subjects With Persistent Asthma Who Remain Uncontrolled While Being Maintained on Montelukast
Status: Enrolling
Updated:  12/18/2013
Clinical Research Facility
2730
mi
from 98109
Miami, FL
Study to Evaluate the Effectiveness and Safety of MK-1029 in the Treatment of Persistent Asthma That is Not Controlled With Montelukast (ML) in Adults (MK-1029-011 AM2)
A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Crossover Study of MK-1029 in Adult Subjects With Persistent Asthma Who Remain Uncontrolled While Being Maintained on Montelukast
Status: Enrolling
Updated: 12/18/2013
Clinical Research Facility
2730
mi
from 98109
Miami, FL
Click here to add this to my saved trials
Study to Evaluate the Effectiveness and Safety of MK-1029 in the Treatment of Persistent Asthma That is Not Controlled With Montelukast (ML) in Adults (MK-1029-011 AM2)
A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Crossover Study of MK-1029 in Adult Subjects With Persistent Asthma Who Remain Uncontrolled While Being Maintained on Montelukast
Status: Enrolling
Updated:  12/18/2013
Clinical Research Facility
396
mi
from 98109
Eagle, ID
Study to Evaluate the Effectiveness and Safety of MK-1029 in the Treatment of Persistent Asthma That is Not Controlled With Montelukast (ML) in Adults (MK-1029-011 AM2)
A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Crossover Study of MK-1029 in Adult Subjects With Persistent Asthma Who Remain Uncontrolled While Being Maintained on Montelukast
Status: Enrolling
Updated: 12/18/2013
Clinical Research Facility
396
mi
from 98109
Eagle, ID
Click here to add this to my saved trials
Study to Evaluate the Effectiveness and Safety of MK-1029 in the Treatment of Persistent Asthma That is Not Controlled With Montelukast (ML) in Adults (MK-1029-011 AM2)
A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Crossover Study of MK-1029 in Adult Subjects With Persistent Asthma Who Remain Uncontrolled While Being Maintained on Montelukast
Status: Enrolling
Updated:  12/18/2013
Clinical Research Facility
1712
mi
from 98109
Normal, IL
Study to Evaluate the Effectiveness and Safety of MK-1029 in the Treatment of Persistent Asthma That is Not Controlled With Montelukast (ML) in Adults (MK-1029-011 AM2)
A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Crossover Study of MK-1029 in Adult Subjects With Persistent Asthma Who Remain Uncontrolled While Being Maintained on Montelukast
Status: Enrolling
Updated: 12/18/2013
Clinical Research Facility
1712
mi
from 98109
Normal, IL
Click here to add this to my saved trials
Study to Evaluate the Effectiveness and Safety of MK-1029 in the Treatment of Persistent Asthma That is Not Controlled With Montelukast (ML) in Adults (MK-1029-011 AM2)
A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Crossover Study of MK-1029 in Adult Subjects With Persistent Asthma Who Remain Uncontrolled While Being Maintained on Montelukast
Status: Enrolling
Updated:  12/18/2013
Clinical Research Facility
2306
mi
from 98109
Gaithersburg, MD
Study to Evaluate the Effectiveness and Safety of MK-1029 in the Treatment of Persistent Asthma That is Not Controlled With Montelukast (ML) in Adults (MK-1029-011 AM2)
A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Crossover Study of MK-1029 in Adult Subjects With Persistent Asthma Who Remain Uncontrolled While Being Maintained on Montelukast
Status: Enrolling
Updated: 12/18/2013
Clinical Research Facility
2306
mi
from 98109
Gaithersburg, MD
Click here to add this to my saved trials
Study to Evaluate the Effectiveness and Safety of MK-1029 in the Treatment of Persistent Asthma That is Not Controlled With Montelukast (ML) in Adults (MK-1029-011 AM2)
A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Crossover Study of MK-1029 in Adult Subjects With Persistent Asthma Who Remain Uncontrolled While Being Maintained on Montelukast
Status: Enrolling
Updated:  12/18/2013
Clinical Research Facility
2511
mi
from 98109
North Dartmouth, MA
Study to Evaluate the Effectiveness and Safety of MK-1029 in the Treatment of Persistent Asthma That is Not Controlled With Montelukast (ML) in Adults (MK-1029-011 AM2)
A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Crossover Study of MK-1029 in Adult Subjects With Persistent Asthma Who Remain Uncontrolled While Being Maintained on Montelukast
Status: Enrolling
Updated: 12/18/2013
Clinical Research Facility
2511
mi
from 98109
North Dartmouth, MA
Click here to add this to my saved trials
Study to Evaluate the Effectiveness and Safety of MK-1029 in the Treatment of Persistent Asthma That is Not Controlled With Montelukast (ML) in Adults (MK-1029-011 AM2)
A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Crossover Study of MK-1029 in Adult Subjects With Persistent Asthma Who Remain Uncontrolled While Being Maintained on Montelukast
Status: Enrolling
Updated:  12/18/2013
Clinical Research Facility
2395
mi
from 98109
Teaneck, NJ
Study to Evaluate the Effectiveness and Safety of MK-1029 in the Treatment of Persistent Asthma That is Not Controlled With Montelukast (ML) in Adults (MK-1029-011 AM2)
A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Crossover Study of MK-1029 in Adult Subjects With Persistent Asthma Who Remain Uncontrolled While Being Maintained on Montelukast
Status: Enrolling
Updated: 12/18/2013
Clinical Research Facility
2395
mi
from 98109
Teaneck, NJ
Click here to add this to my saved trials
Study to Evaluate the Effectiveness and Safety of MK-1029 in the Treatment of Persistent Asthma That is Not Controlled With Montelukast (ML) in Adults (MK-1029-011 AM2)
A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Crossover Study of MK-1029 in Adult Subjects With Persistent Asthma Who Remain Uncontrolled While Being Maintained on Montelukast
Status: Enrolling
Updated:  12/18/2013
Clinical Research Facility
2052
mi
from 98109
Canton, OH
Study to Evaluate the Effectiveness and Safety of MK-1029 in the Treatment of Persistent Asthma That is Not Controlled With Montelukast (ML) in Adults (MK-1029-011 AM2)
A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Crossover Study of MK-1029 in Adult Subjects With Persistent Asthma Who Remain Uncontrolled While Being Maintained on Montelukast
Status: Enrolling
Updated: 12/18/2013
Clinical Research Facility
2052
mi
from 98109
Canton, OH
Click here to add this to my saved trials
Study to Evaluate the Effectiveness and Safety of MK-1029 in the Treatment of Persistent Asthma That is Not Controlled With Montelukast (ML) in Adults (MK-1029-011 AM2)
A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Crossover Study of MK-1029 in Adult Subjects With Persistent Asthma Who Remain Uncontrolled While Being Maintained on Montelukast
Status: Enrolling
Updated:  12/18/2013
Clinical Research Facility
2352
mi
from 98109
Collegeville, PA
Study to Evaluate the Effectiveness and Safety of MK-1029 in the Treatment of Persistent Asthma That is Not Controlled With Montelukast (ML) in Adults (MK-1029-011 AM2)
A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Crossover Study of MK-1029 in Adult Subjects With Persistent Asthma Who Remain Uncontrolled While Being Maintained on Montelukast
Status: Enrolling
Updated: 12/18/2013
Clinical Research Facility
2352
mi
from 98109
Collegeville, PA
Click here to add this to my saved trials
Study to Evaluate the Effectiveness and Safety of MK-1029 in the Treatment of Persistent Asthma That is Not Controlled With Montelukast (ML) in Adults (MK-1029-011 AM2)
A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Crossover Study of MK-1029 in Adult Subjects With Persistent Asthma Who Remain Uncontrolled While Being Maintained on Montelukast
Status: Enrolling
Updated:  12/18/2013
Clinical Research Facility
2487
mi
from 98109
Warwick, RI
Study to Evaluate the Effectiveness and Safety of MK-1029 in the Treatment of Persistent Asthma That is Not Controlled With Montelukast (ML) in Adults (MK-1029-011 AM2)
A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Crossover Study of MK-1029 in Adult Subjects With Persistent Asthma Who Remain Uncontrolled While Being Maintained on Montelukast
Status: Enrolling
Updated: 12/18/2013
Clinical Research Facility
2487
mi
from 98109
Warwick, RI
Click here to add this to my saved trials
Study to Evaluate the Effectiveness and Safety of MK-1029 in the Treatment of Persistent Asthma That is Not Controlled With Montelukast (ML) in Adults (MK-1029-011 AM2)
A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Crossover Study of MK-1029 in Adult Subjects With Persistent Asthma Who Remain Uncontrolled While Being Maintained on Montelukast
Status: Enrolling
Updated:  12/18/2013
Clinical Research Facility
706
mi
from 98109
Murray, UT
Study to Evaluate the Effectiveness and Safety of MK-1029 in the Treatment of Persistent Asthma That is Not Controlled With Montelukast (ML) in Adults (MK-1029-011 AM2)
A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Crossover Study of MK-1029 in Adult Subjects With Persistent Asthma Who Remain Uncontrolled While Being Maintained on Montelukast
Status: Enrolling
Updated: 12/18/2013
Clinical Research Facility
706
mi
from 98109
Murray, UT
Click here to add this to my saved trials
Transporter Mediated Uptake of Montelukast
Characterization of Transporter Mediated Uptake of Montelukast in Humans
Status: Enrolling
Updated:  1/23/2014
Nemours Children's Clinic
2452
mi
from 98109
Jacksonville, FL
Transporter Mediated Uptake of Montelukast
Characterization of Transporter Mediated Uptake of Montelukast in Humans
Status: Enrolling
Updated: 1/23/2014
Nemours Children's Clinic
2452
mi
from 98109
Jacksonville, FL
Click here to add this to my saved trials
Genotype Stratified Pharmacokinetic Study of Montelukast
Genotype Stratified Pharmacokinetic Study of Montelukast
Status: Enrolling
Updated:  1/23/2014
Nemours Children's Clinic
2452
mi
from 98109
Jacksonville, FL
Genotype Stratified Pharmacokinetic Study of Montelukast
Genotype Stratified Pharmacokinetic Study of Montelukast
Status: Enrolling
Updated: 1/23/2014
Nemours Children's Clinic
2452
mi
from 98109
Jacksonville, FL
Click here to add this to my saved trials
Safety, Tolerability, and Efficacy of AIN457 in Patients With Uncontrolled Asthma
A Randomized, Double-blind, Placebo Controlled, Multiple Dose Study to Evaluate the Safety, Tolerability, and Efficacy of Intravenous Administration of Secukinumab (AIN457) in Patients With Asthma Not Adequately Controlled With Inhaled Corticosteroids and Long Acting Beta-agonists.
Status: Enrolling
Updated:  1/27/2014
Novartis Investigative Site
979
mi
from 98109
Anaheim, CA
Safety, Tolerability, and Efficacy of AIN457 in Patients With Uncontrolled Asthma
A Randomized, Double-blind, Placebo Controlled, Multiple Dose Study to Evaluate the Safety, Tolerability, and Efficacy of Intravenous Administration of Secukinumab (AIN457) in Patients With Asthma Not Adequately Controlled With Inhaled Corticosteroids and Long Acting Beta-agonists.
Status: Enrolling
Updated: 1/27/2014
Novartis Investigative Site
979
mi
from 98109
Anaheim, CA
Click here to add this to my saved trials
Safety, Tolerability, and Efficacy of AIN457 in Patients With Uncontrolled Asthma
A Randomized, Double-blind, Placebo Controlled, Multiple Dose Study to Evaluate the Safety, Tolerability, and Efficacy of Intravenous Administration of Secukinumab (AIN457) in Patients With Asthma Not Adequately Controlled With Inhaled Corticosteroids and Long Acting Beta-agonists.
Status: Enrolling
Updated:  1/27/2014
Novartis Investigative Site
2725
mi
from 98109
Aventura, FL
Safety, Tolerability, and Efficacy of AIN457 in Patients With Uncontrolled Asthma
A Randomized, Double-blind, Placebo Controlled, Multiple Dose Study to Evaluate the Safety, Tolerability, and Efficacy of Intravenous Administration of Secukinumab (AIN457) in Patients With Asthma Not Adequately Controlled With Inhaled Corticosteroids and Long Acting Beta-agonists.
Status: Enrolling
Updated: 1/27/2014
Novartis Investigative Site
2725
mi
from 98109
Aventura, FL
Click here to add this to my saved trials
Safety, Tolerability, and Efficacy of AIN457 in Patients With Uncontrolled Asthma
A Randomized, Double-blind, Placebo Controlled, Multiple Dose Study to Evaluate the Safety, Tolerability, and Efficacy of Intravenous Administration of Secukinumab (AIN457) in Patients With Asthma Not Adequately Controlled With Inhaled Corticosteroids and Long Acting Beta-agonists.
Status: Enrolling
Updated:  1/27/2014
Novartis Investigative site
2485
mi
from 98109
Boston, MA
Safety, Tolerability, and Efficacy of AIN457 in Patients With Uncontrolled Asthma
A Randomized, Double-blind, Placebo Controlled, Multiple Dose Study to Evaluate the Safety, Tolerability, and Efficacy of Intravenous Administration of Secukinumab (AIN457) in Patients With Asthma Not Adequately Controlled With Inhaled Corticosteroids and Long Acting Beta-agonists.
Status: Enrolling
Updated: 1/27/2014
Novartis Investigative site
2485
mi
from 98109
Boston, MA
Click here to add this to my saved trials
Safety, Tolerability, and Efficacy of AIN457 in Patients With Uncontrolled Asthma
A Randomized, Double-blind, Placebo Controlled, Multiple Dose Study to Evaluate the Safety, Tolerability, and Efficacy of Intravenous Administration of Secukinumab (AIN457) in Patients With Asthma Not Adequately Controlled With Inhaled Corticosteroids and Long Acting Beta-agonists.
Status: Enrolling
Updated:  1/27/2014
Novartis Investigative Site
2360
mi
from 98109
Raleigh, NC
Safety, Tolerability, and Efficacy of AIN457 in Patients With Uncontrolled Asthma
A Randomized, Double-blind, Placebo Controlled, Multiple Dose Study to Evaluate the Safety, Tolerability, and Efficacy of Intravenous Administration of Secukinumab (AIN457) in Patients With Asthma Not Adequately Controlled With Inhaled Corticosteroids and Long Acting Beta-agonists.
Status: Enrolling
Updated: 1/27/2014
Novartis Investigative Site
2360
mi
from 98109
Raleigh, NC
Click here to add this to my saved trials
Safety, Tolerability, and Efficacy of AIN457 in Patients With Uncontrolled Asthma
A Randomized, Double-blind, Placebo Controlled, Multiple Dose Study to Evaluate the Safety, Tolerability, and Efficacy of Intravenous Administration of Secukinumab (AIN457) in Patients With Asthma Not Adequately Controlled With Inhaled Corticosteroids and Long Acting Beta-agonists.
Status: Enrolling
Updated:  1/27/2014
Novartis Investigative Site
2274
mi
from 98109
Winston-Salem, NC
Safety, Tolerability, and Efficacy of AIN457 in Patients With Uncontrolled Asthma
A Randomized, Double-blind, Placebo Controlled, Multiple Dose Study to Evaluate the Safety, Tolerability, and Efficacy of Intravenous Administration of Secukinumab (AIN457) in Patients With Asthma Not Adequately Controlled With Inhaled Corticosteroids and Long Acting Beta-agonists.
Status: Enrolling
Updated: 1/27/2014
Novartis Investigative Site
2274
mi
from 98109
Winston-Salem, NC
Click here to add this to my saved trials
Safety, Tolerability, and Efficacy of AIN457 in Patients With Uncontrolled Asthma
A Randomized, Double-blind, Placebo Controlled, Multiple Dose Study to Evaluate the Safety, Tolerability, and Efficacy of Intravenous Administration of Secukinumab (AIN457) in Patients With Asthma Not Adequately Controlled With Inhaled Corticosteroids and Long Acting Beta-agonists.
Status: Enrolling
Updated:  1/27/2014
Novartis Investigative Site
2242
mi
from 98109
Spartanburg, SC
Safety, Tolerability, and Efficacy of AIN457 in Patients With Uncontrolled Asthma
A Randomized, Double-blind, Placebo Controlled, Multiple Dose Study to Evaluate the Safety, Tolerability, and Efficacy of Intravenous Administration of Secukinumab (AIN457) in Patients With Asthma Not Adequately Controlled With Inhaled Corticosteroids and Long Acting Beta-agonists.
Status: Enrolling
Updated: 1/27/2014
Novartis Investigative Site
2242
mi
from 98109
Spartanburg, SC
Click here to add this to my saved trials
CYT003 in Patients With Mild to Moderate Allergic Asthma Not Sufficiently Controlled on Inhaled Glucocorticosteroids
A Randomized, Placebo-Controlled, Phase IIb Study of CYT003-QbG10 (CYT003), a TLR9 Agonist, in Patients With Mild to Moderate Allergic Asthma Not Sufficiently Controlled on Inhaled Glucocorticosteroids
Status: Enrolling
Updated:  3/12/2014
University of South Florida
2523
mi
from 98109
Tampa, FL
CYT003 in Patients With Mild to Moderate Allergic Asthma Not Sufficiently Controlled on Inhaled Glucocorticosteroids
A Randomized, Placebo-Controlled, Phase IIb Study of CYT003-QbG10 (CYT003), a TLR9 Agonist, in Patients With Mild to Moderate Allergic Asthma Not Sufficiently Controlled on Inhaled Glucocorticosteroids
Status: Enrolling
Updated: 3/12/2014
University of South Florida
2523
mi
from 98109
Tampa, FL
Click here to add this to my saved trials
Sub-Sensitivity to Long-Acting Bronchodilators (LABA)
Sub-Sensitivity to Long-Acting Bronchodilators (LABA)
Status: Enrolling
Updated:  3/13/2014
National Jewish Health
1022
mi
from 98109
Denver, CO
Sub-Sensitivity to Long-Acting Bronchodilators (LABA)
Sub-Sensitivity to Long-Acting Bronchodilators (LABA)
Status: Enrolling
Updated: 3/13/2014
National Jewish Health
1022
mi
from 98109
Denver, CO
Click here to add this to my saved trials
Drug Delivery Via Pressurized Metered-dose Inhaler and Valved Holding Chamber in Asthmatic Children: Determination of Delivered Dose Following Coordinated and Uncoordinated Use
Drug Delivery Via Pressurized Metered-dose Inhaler and Valved Holding Chamber in Asthmatic Children: Determination of Delivered Dose Following Coordinated and Uncoordinated Use
Status: Enrolling
Updated:  4/21/2014
Arkansas Children's Hospital
1782
mi
from 98109
Little Rock, AR
Drug Delivery Via Pressurized Metered-dose Inhaler and Valved Holding Chamber in Asthmatic Children: Determination of Delivered Dose Following Coordinated and Uncoordinated Use
Drug Delivery Via Pressurized Metered-dose Inhaler and Valved Holding Chamber in Asthmatic Children: Determination of Delivered Dose Following Coordinated and Uncoordinated Use
Status: Enrolling
Updated: 4/21/2014
Arkansas Children's Hospital
1782
mi
from 98109
Little Rock, AR
Click here to add this to my saved trials
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated:  4/24/2014
GSK Investigational Site
1779
mi
from 98109
Little Rock, AR
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated: 4/24/2014
GSK Investigational Site
1779
mi
from 98109
Little Rock, AR
Click here to add this to my saved trials
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated:  4/24/2014
GSK Investigational Site
991
mi
from 98109
Costa Mesa, CA
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated: 4/24/2014
GSK Investigational Site
991
mi
from 98109
Costa Mesa, CA
Click here to add this to my saved trials
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated:  4/24/2014
GSK Investigational Site
987
mi
from 98109
Huntington Beach, CA
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated: 4/24/2014
GSK Investigational Site
987
mi
from 98109
Huntington Beach, CA
Click here to add this to my saved trials
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated:  4/24/2014
GSK Investigational Site
980
mi
from 98109
Long Beach, CA
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated: 4/24/2014
GSK Investigational Site
980
mi
from 98109
Long Beach, CA
Click here to add this to my saved trials
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated:  4/24/2014
GSK Investigational Site
995
mi
from 98109
Newport Beach, CA
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated: 4/24/2014
GSK Investigational Site
995
mi
from 98109
Newport Beach, CA
Click here to add this to my saved trials
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated:  4/24/2014
GSK Investigational Site
984
mi
from 98109
Orange, CA
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated: 4/24/2014
GSK Investigational Site
984
mi
from 98109
Orange, CA
Click here to add this to my saved trials
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated:  4/24/2014
GSK Investigational Site
978
mi
from 98109
Rolling Hills Estates, CA
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated: 4/24/2014
GSK Investigational Site
978
mi
from 98109
Rolling Hills Estates, CA
Click here to add this to my saved trials
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated:  4/24/2014
GSK Investigational Site
2725
mi
from 98109
Aventura, FL
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated: 4/24/2014
GSK Investigational Site
2725
mi
from 98109
Aventura, FL
Click here to add this to my saved trials
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated:  4/24/2014
GSK Investigational Site
2575
mi
from 98109
Cocoa, FL
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated: 4/24/2014
GSK Investigational Site
2575
mi
from 98109
Cocoa, FL
Click here to add this to my saved trials
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated:  4/24/2014
GSK Investigational Site
2730
mi
from 98109
Miami, FL
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated: 4/24/2014
GSK Investigational Site
2730
mi
from 98109
Miami, FL
Click here to add this to my saved trials
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated:  4/24/2014
GSK Investigational Site
2202
mi
from 98109
Columbus, GA
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated: 4/24/2014
GSK Investigational Site
2202
mi
from 98109
Columbus, GA
Click here to add this to my saved trials
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated:  4/24/2014
GSK Investigational Site
396
mi
from 98109
Eagle, ID
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated: 4/24/2014
GSK Investigational Site
396
mi
from 98109
Eagle, ID
Click here to add this to my saved trials
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated:  4/24/2014
GSK Investigational Site
1712
mi
from 98109
Normal, IL
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated: 4/24/2014
GSK Investigational Site
1712
mi
from 98109
Normal, IL
Click here to add this to my saved trials
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated:  4/24/2014
GSK Investigational Site
1737
mi
from 98109
Shiloh, IL
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated: 4/24/2014
GSK Investigational Site
1737
mi
from 98109
Shiloh, IL
Click here to add this to my saved trials
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated:  4/24/2014
GSK Investigational Site
1501
mi
from 98109
Lenexa, KA
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated: 4/24/2014
GSK Investigational Site
1501
mi
from 98109
Lenexa, KA
Click here to add this to my saved trials
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated:  4/24/2014
GSK Investigational Site
1894
mi
from 98109
Owensboro, KY
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated: 4/24/2014
GSK Investigational Site
1894
mi
from 98109
Owensboro, KY
Click here to add this to my saved trials
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated:  4/24/2014
GSK Investigational Site
1781
mi
from 98109
Stevensville, MI
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated: 4/24/2014
GSK Investigational Site
1781
mi
from 98109
Stevensville, MI
Click here to add this to my saved trials
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated:  4/24/2014
GSK Investigational Site
1381
mi
from 98109
Plymouth, MN
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated: 4/24/2014
GSK Investigational Site
1381
mi
from 98109
Plymouth, MN
Click here to add this to my saved trials
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated:  4/24/2014
GSK Investigational Site
1611
mi
from 98109
Columbia, MO
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated: 4/24/2014
GSK Investigational Site
1611
mi
from 98109
Columbia, MO
Click here to add this to my saved trials
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated:  4/24/2014
GSK Investigational Site
1674
mi
from 98109
Rolla, MO
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated: 4/24/2014
GSK Investigational Site
1674
mi
from 98109
Rolla, MO
Click here to add this to my saved trials
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated:  4/24/2014
GSK Investigational Site
2216
mi
from 98109
Corning, NY
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated: 4/24/2014
GSK Investigational Site
2216
mi
from 98109
Corning, NY
Click here to add this to my saved trials
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated:  4/24/2014
GSK Investigational Site
2356
mi
from 98109
Raleigh, NC
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated: 4/24/2014
GSK Investigational Site
2356
mi
from 98109
Raleigh, NC
Click here to add this to my saved trials
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated:  4/24/2014
GSK Investigational Site
2053
mi
from 98109
Canton, OH
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated: 4/24/2014
GSK Investigational Site
2053
mi
from 98109
Canton, OH
Click here to add this to my saved trials
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated:  4/24/2014
GSK Investigational Site
1966
mi
from 98109
Cincinnati, OH
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated: 4/24/2014
GSK Investigational Site
1966
mi
from 98109
Cincinnati, OH
Click here to add this to my saved trials
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated:  4/24/2014
GSK Investigational Site
1519
mi
from 98109
Oklahoma City, OK
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated: 4/24/2014
GSK Investigational Site
1519
mi
from 98109
Oklahoma City, OK
Click here to add this to my saved trials
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated:  4/24/2014
GSK Investigational Site
367
mi
from 98109
Medford, OR
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated: 4/24/2014
GSK Investigational Site
367
mi
from 98109
Medford, OR
Click here to add this to my saved trials
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated:  4/24/2014
GSK Investigational Site
145
mi
from 98109
Portland, OR
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated: 4/24/2014
GSK Investigational Site
145
mi
from 98109
Portland, OR
Click here to add this to my saved trials
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated:  4/24/2014
GSK Investigational Site
2134
mi
from 98109
Pittsburgh, PA
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated: 4/24/2014
GSK Investigational Site
2134
mi
from 98109
Pittsburgh, PA
Click here to add this to my saved trials